Westaim
Toronto
About Westaim
Westaim Corporation invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim holds a 75 per cent interest in NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Westaim's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $338.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2024)
- Ticker: otcpink:WEDXF
- Website: westaim.com
- Phone: 416-969-3333
Industries & Categories
Finance, Financial Services, Venture Capital
Social Profiles
Canonical: https://fsome.com/organization/westaim-198698 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.